Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Company profile
Ticker
TMO
Exchange
Website
CEO
Marc Casper
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
THERMO ELECTRON CORP
SEC CIK
Corporate docs
Subsidiaries
0972792 B.C. LTD • 236 Perinton Parkway, LLC • 27 Forge Parkway LLC • Abgene Inc. • Abgene Limited • ABII 2 Limited • ACI Holdings Inc. • Acoustic Cytometry Systems, Inc. • AcroMetrix LLC • Acros Organics BV ...
IRS number
42209186
TMO stock data
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
24 Apr 24
8-K
Thermo Fisher Scientific Reports First Quarter 2024 Results
24 Apr 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
6 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
1 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
31 Jan 24
Transcripts
TMO
Earnings call transcript
2024 Q1
24 Apr 24
TMO
Earnings call transcript
2023 Q4
31 Jan 24
TMO
Earnings call transcript
2023 Q3
25 Oct 23
TMO
Earnings call transcript
2023 Q2
26 Jul 23
TMO
Earnings call transcript
2023 Q2
26 Jul 23
TMO
Earnings call transcript
2023 Q1
26 Apr 23
TMO
Earnings call transcript
2022 Q4
1 Feb 23
TMO
Earnings call transcript
2022 Q3
26 Oct 22
TMO
Earnings call transcript
2022 Q2
28 Jul 22
TMO
Earnings call transcript
2022 Q1
28 Apr 22
Latest ownership filings
4
R. Alexandra Keith
2 Apr 24
4
SCOTT M SPERLING
2 Apr 24
4
DION J WEISLER
2 Apr 24
4
JENNIFER M JOHNSON
2 Apr 24
4
Joseph R. Holmes
27 Mar 24
4
Science 37 Holdings, Inc.
14 Mar 24
4
Science 37 Holdings, Inc.
14 Mar 24
3/A
Science 37 Holdings, Inc.
14 Mar 24
SC 13D/A
Science 37 Holdings, Inc.
14 Mar 24
4
MARC N CASPER
14 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jul 23 | Apr 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
70.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2064 |
Opened positions | 227 |
Closed positions | 470 |
Increased positions | 733 |
Reduced positions | 821 |
13F shares | Current |
---|---|
Total value | 122.98 tn |
Total shares | 268.08 mm |
Total puts | 689.38 k |
Total calls | 557.00 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 32.98 mm | $17.50 tn |
STT State Street | 16.48 mm | $8.75 tn |
MS Morgan Stanley | 12.55 mm | $6.66 tn |
Whalerock Point Partners | 12.44 mm | $6.60 bn |
Capital World Investors | 12.26 mm | $6.51 tn |
T. Rowe Price | 9.90 mm | $5.25 bn |
Capital Research Global Investors | 7.99 mm | $4.24 tn |
FMR | 7.85 mm | $4.17 tn |
Massachusetts Financial Services | 4.18 mm | $2.22 tn |
NTRS Northern Trust | 3.79 mm | $2.01 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Mar 24 | Jennifer M Johnson | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 53.77 | 0.00 | 167.59 |
30 Mar 24 | Weisler Dion J | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 64.52 | 0.00 | 2,125.43 |
30 Mar 24 | Sperling Scott M | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 70.97 | 0.00 | 16,931.28 |
30 Mar 24 | R. Alexandra Keith | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 53.77 | 0.00 | 776.72 |
25 Mar 24 | Joseph R. Holmes | Common Stock | Grant | Acquire A | No | No | 0 | 46 | 0.00 | 1,790.588 |
News
Barclays Maintains Equal-Weight on Thermo Fisher Scientific, Raises Price Target to $615
25 Apr 24
Deutsche Bank Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $610
25 Apr 24
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings
25 Apr 24
7 Analysts Assess Thermo Fisher Scientific: What You Need To Know
25 Apr 24
Baird Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $620
25 Apr 24
Press releases
Thermo Fisher Scientific to Host Investor Day
24 Apr 24
Thermo Fisher Scientific Reports First Quarter 2024 Results
24 Apr 24
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
1 Mar 24
Thermo Fisher Scientific Increases Quarterly Dividend
21 Feb 24
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
31 Jan 24